Xenotransplantation of human unrestricted somatic stem cells in a pig model of acute myocardial infarction

Xenotransplantation

Volumn 20, Issue 2, 2013, Pages 110-122

  Gahremanpour, Amir ^a   Vela, Deborah ^b   Zheng, Yi ^a   Silva, Guilherme V ^a   Fodor, William ^c   Cardoso, Cristiano O ^a   Baimbridge, Fred ^a   Fernandes, Marlos R ^a   Buja, L Maximilian ^b,d   Perin, Emerson C ^a  

^a TEXAS HEART INSTITUTE   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c Cell Therapy Group   (Canada)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

cord blood stem cell transplantation; heterologous; myocardial infarction; pluripotent stem cells; transplantation

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; MITOCHONDRION ANTIBODY; PHOSPHATE BUFFERED SALINE; PLACEBO; PREDNISONE;

ACUTE HEART INFARCTION; ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELL TYPE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ECHOCARDIOGRAPHY; HEART FUNCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL; STEM CELL; STEM CELL TRANSPLANTATION; SWINE; UNRESTRICTED SOMATIC STEM CELL; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; ANTIGENS, HETEROPHILE; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; HEART FUNCTION TESTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MITOCHONDRIA; MYOCARDIAL INFARCTION; PLURIPOTENT STEM CELLS; RANDOM ALLOCATION; SUS SCROFA; TRANSPLANTATION, HETEROLOGOUS; TREATMENT FAILURE;

EID: 84875800507     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12026     Document Type: Article

References (35)

1. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 989-997.
2. Lee J, Terracciano CM,. Cell therapy for cardiac repair. Br Med Bull 2010; 94: 65-80.
3. Lipinski MJ, Biondi-Zoccai GG, Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007; 50: 1761-1767.
4. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294-2302.
5. van der Spoel TI, Jansen OF Lorkeers SJ, Agostoni P, et al. Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc Res 2011; 91: 649-658.
6. Greschat S, Schira J, Kury P, et al. Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev 2008; 17: 221-232.
7. Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200: 123-135.
8. Sensken S, Waclawczyk S, Knaupp AS, et al. In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherapy 2007; 9: 362-378.
9. Seyedjafari E, Soleimani M, Ghaemi N, Sarbolouki MN,. Enhanced osteogenic differentiation of cord blood-derived unrestricted somatic stem cells on electrospun nanofibers. J Mater Sci Mater Med 2011; 22: 165-174.
10. Waclawczyk S, Buchheiser A, Flogel U, Radke TF, Kogler G,. In vitro differentiation of unrestricted somatic stem cells into functional hepatic-like cells displaying a hepatocyte-like glucose metabolism. J Cell Physiol 2010; 225: 545-554.
11. Kogler G, Sensken S, Wernet P,. Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Exp Hematol 2006; 34: 1589-1595.
12. Kim BO, Tian H, Prasongsukarn K, et al. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005; 112: I96-I104.
13. Moelker AD, Baks T, Wever KM, et al. Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve lv function after myocardial infarction in swine. J Mol Cell Cardiol 2007; 42: 735-745.
14. Ghodsizad A, Niehaus M, Kogler G, et al. Transplanted human cord blood-derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction. Heart 2009; 95: 27-35.
15. Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006; 27: 1114-1122.
16. Vulliet PR, Greeley M, Halloran SM, Macdonald KA, Kittleson MD,. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004; 363: 783-784.
17. Perin EC, Silva GV, Assad JA, et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 2008; 44: 486-495.
18. Vale PR, Losordo DW, Milliken CE, et al. Left ventricular electromechanical mapping to assess efficacy of phvegf(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 2000; 102: 965-974.
19. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the american heart association. Circulation 2002; 105: 539-542.
20. Winter M, Wang XN, Daubener W, et al. Suppression of cellular immunity by cord blood-derived unrestricted somatic stem cells is cytokine-dependent. J Cell Mol Med 2009; 13: 2465-2475.
21. Gotherstrom C,. Immunomodulation by multipotent mesenchymal stromal cells. Transplantation 2007; 84: S35-S37.
22. Inoue S, Popp FC, Koehl GE, et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 2006; 81: 1589-1595.
23. Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific t cells to their cognate peptide. Blood 2003; 101: 3722-3729.
24. Nauta AJ, Fibbe WE,. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499-3506.
25. Cho PS, Messina DJ, Hirsh EL, et al. Immunogenicity of umbilical cord tissue derived cells. Blood 2008; 111: 430-438.
26. Poncelet AJ, Vercruysse J, Saliez A, Gianello P,. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 2007; 83: 783-790.
27. Frangogiannis NG, Smith CW, Entman ML,. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31-47.
28. Cascalho M, Platt JL,. The immunological barrier to xenotransplantation. Immunity 2001; 14: 437-446.
29. Yang YG,. Cd47 in xenograft rejection and tolerance induction. Xenotransplantation 2010; 17: 267-273.
30. Xiao YF, Min JY, Morgan JP,. Immunosuppression and xenotransplantation of cells for cardiac repair. Ann Thorac Surg 2004; 77: 737-744.
31. Haider H, Jiang SJ, Ye L, et al. Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair. Transplant Proc 2004; 36: 232-235.
32. Copland IB, Galipeau J,. Death and inflammation following somatic cell transplantation. Semin Immunopathol 2011; 33: 535-550.
33. Hamamoto H, Gorman JH, Ryan LP, et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg 2009; 87: 794-801.
34. Quevedo HC, Hatzistergos KE, Oskouei BN, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 2009; 106: 14022-14027.
35. Vela DC, Silva GV, Assad JA, et al. Histopathological study of healing after allogenic mesenchymal stem cell delivery in myocardial infarction in dogs. J Histochem Cytochem 2009; 57: 167-176.